mesenchymal stem cells therapy No Further a Mystery
In contrast to investigations describing the professional-angiogenic outcome of MSCs (Zhang et al., 2013; Li et al., 2016), the anti-tumor activity of MSCs by way of inhibition of tumor angiogenesis has also been documented. A review claimed that bone marrow MSCs restrict vascular expansion in ΔGli36 glioma xenograft through downregulation of the